GNBPD Stock | News | Quote | Stock Forum | Sunday, October 13,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Lion Biotechnologies, Inc. GNBPD Company Overview 

Stock Message Board http://investorshangout.com/search?q=GNBPD&am...mp;yt1=Go!

Last Updated: Sunday, October 13, 2013 04:38:28 AM

Lion Biotechnologies, Inc. GNBPD Current Price and Quotes
Last Price 7.00
Previous Close 7.75 Open 7.30
Daily Range 7.32 - 5.76 52wk Range 50.00 - 1.01
Volume 3,720 Dividend N/A
Average Vol (3m) 5,759 Yield N/A
Lion Biotechnologies, Inc. GNBPD
Company Information

10960 Wilshire Blvd.
Suite 1050
Los Angeles, CA 90024

Website: http://www.genesis-biopharma.com
Phone: 866-963-2220
Email: info@genesis-biopharma.com

Lion Biotechnologies, Inc. GNBPD
Lion Biotechnologies, Inc. GNBPD
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Dec 31, 2012 10-K
CIK 0001425205
Fiscal Year End 12/31
OTC Marketplace OTC Pink Limited
Profile Data

SIC - Industry Classification 4731 - Freight transportation arranging
Business Status Development Stage Company a/o Mar 31, 2008
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Merrill A. McPeak Interim CEO
Michael Handelman Treasurer, CFO, Secretary
Company Directors

William Andrews
Anthony Cataldo
L. Stephen Coles
Michael Handelman
Merrill A. McPeak
David Voyticky
Company Notes

Formerly=Genesis Biopharma, Inc. until 9-2013
Formerly=Freight Management Corp. until 4-2010
Service Providers

Auditor/Accountant
Weinberg & Company, P.A.
6100 Glades Road
Suite 314
Boca Raton, FL, 33434
Legal Counsel
Not Available
Investor Relations Firm
Lippert/Heilshorn & Associates
800 Third Avenue
New York, NY, 10022
United States


Lion Biotechnologies, Inc. GNBPD
GNBPD Security Details

Share Structure

Market Value1 $105,656,684 a/o Oct 11, 2013
Shares Outstanding 15,093,812 a/o Sep 26, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record Not Available
Security Notes

Capital Change=shs increased by 24 for 1 split, payable upon surrender. Pay date=04/06/2010.
Capital Change=shs decreased by 1 for 100 split. Ex-date=09/26/2013.
Short Selling Data

Short Interest 0 (-100%)
Sep 13, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Corporate Stock Transfer, Inc.

Lion Biotechnologies, Inc. GNBPD Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development 1,656 1,756 171 -
Sales, General and Admin. 6,477 19,303 644 16
Non-Recurring Items - 160 - -
Other - - - -
Operating Income (8,133) (21,218) (815) (16)
Income From Continuing Operations

Add'l Income/Expense Items 6,747 (4,324) (793) -
Earnings Before Interest and Tax (1,386) (25,543) (1,608) (16)
Interest Expense 1,922 152 - -
Earnings Before Tax (3,308) (25,694) (1,608) (16)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,308) (25,694) (1,608) (16)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,308) (25,694) (1,608) (16)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (3,308) (25,694) (1,608) (16)

Lion Biotechnologies, Inc. GNBPD Recent News

Oct 7, 2013 Lion Biotechnologies to Present at the 12th Annual BIO Investor Forum on October 9
Sept 30, 2013 Lion Biotechnologies Provides Update on Phase II Results for Metastatic Melanoma
Sept 27, 2013 Lion Biotechnologies to Present at the LD Micro Invitational on October 2
Sept 5, 2013 Genesis Biopharma Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
Aug 8, 2013 Genesis Biopharma Issues Letter to Shareholders
Jul 30, 2013 Genesis Biopharma Appoints New Members to Board of Directors
Jul 25, 2013 Genesis Biopharma Announces Completion of Merger with Lion Biotechnologies


GNBPD Lion Biotechnologies, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=GNBPD&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GNBPD/quote
Stock Chart http://www.otcmarkets.com/stock/GNBPD/chart
Company Info http://www.otcmarkets.com/stock/GNBPD/company-info
Recent News http://www.otcmarkets.com/stock/GNBPD/news
Financials http://www.otcmarkets.com/stock/GNBPD/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GNBPD/filings
Short Sales http://www.otcmarkets.com/stock/GNBPD/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GNBPD/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GNBPD/research
Summary http://finance.yahoo.com/q?s=GNBPD
Historical Prices http://finance.yahoo.com/q/hp?s=GNBPD+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GNBPD
Basic Chart http://finance.yahoo.com/q/bc?s=GNBPD+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GNBPD+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GNBPD+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GNBPD+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GNBPD+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GNBPD+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GNBPD+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GNBPD+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GNBPD+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GNBPD+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GNBPD
Balance Sheet http://finance.yahoo.com/q/bs?s=GNBPD
Cash Flow http://finance.yahoo.com/q/cf?s=GNBPD+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GNBPD
Market Watch http://www.marketwatch.com/investing/stock/GNBPD
Bloomberg http://www.bloomberg.com/quote/GNBPD:US
Morningstar http://quotes.morningstar.com/stock/s?t=GNBPD
Bussinessweek http://investing.businessweek.com/research/st...cker=GNBPD
Barchart http://www.barchart.com/quotes/stocks/GNBPD
OTC Short Report http://otcshortreport.com/index.php?index=GNBPD
Investopedia http://www.investopedia.com/markets/stocks/GNBPD/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 37

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 25

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 34

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 20

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 30

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 31

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 35

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Challenges Faced by Oncternal Therapeutics and Stock Update

Updated Category News Views 98

Oncternal Therapeutics Inc. (ONCT) was in dire straits back then, hitting a notable low of $1.31 amidst a turbulent market that left investors biting their nails. This stock plunge represented a hefty drop of -76.33%, rattling traders who were already on edge over the biopharmaceutical company’s struggle to bring innovative cancer therapies to market. The company's...

Continue Reading
Reltio Enhances Global Data Cloud and AI Infrastructure Reach

Updated Category News Views 52

Reltio Expands Their Cloud and AI Infrastructure Worldwide Reltio, the leader in AI-driven data unification and management, has announced its ambitious plans to enhance its data cloud and AI infrastructure on a global scale. This expansion will see the company establish new data sovereignty regions to cater to the growing enterprise demand in various sections of the...

Continue Reading
Join The Inner Mountain Foundation's New Global Community

Updated Category News Views 151

Introducing the Inner Mountain Foundation's Global Community Become a part of the Inner Mountain online community for free and connect with others who share your passion for social transformation through empowering individuals. The Inner Mountain Foundation, an organization dedicated to individual empowerment on a global scale, has unveiled its exciting new online...

Continue Reading
Pan American Energy Completes Phase 2 Earn-In for Big Mack

Updated Category News Views 269

Pan American Energy Achieves Key Milestone Pan American Energy Corp. (CSE: PNRG | OTCQB: PAANF | FRA: SS60) is excited to share that it has successfully completed the Phase Two earn-in payments and work expenditures. This achievement includes C$400,000 in Pan American shares and C$1,120,000 in exploration costs under the Big Mack Option Agreement with Magabra Resources...

Continue Reading
GBP/USD and Oil Trends: Key Insights for Traders

Updated Category News Views 111

GBP/USD Rises Ahead of US CPI Data Recent market movements have shown an upward trend for GBP/USD as traders look ahead to crucial US CPI data. The expectation is for this data to stabilize at 2.7% year-over-year. This anticipation, combined with growing concerns over the independence of the Federal Reserve, has added pressure on the US dollar. GBP/USD has climbed for a...

Continue Reading